Patient basic information Patient:Michelle (Michelle Anderson) Nationality: Oman Disease Diagnosis: Facial myasthenia gravis Diagnostic hospital: Hemp treatment: Blood stem cell transplant + chemotherapy Hospitalization: 75 days Treatment cost: about 115,389 yuan Treatment effect: pain relief Describing the condition Ms. Michelle is from Oman, where she was diagnosed with facial myasthenia gravis. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process.
The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs. After 75 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached hospital standards. Treatment results: Patient's pain was finally relieved.
At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track recovery through a remote follow-up system. Patients commented: 'We are impressed with the level of expertise of Chinese doctors and the condition of equipment at Chinese hospitals. 'Mrs.
Michelle Liu, this case has been criticized by experts as a typical case of cross-border suspected seriousness clinical cases. Liu4 Liu relies on multidisciplinary collaborative mechanisms to develop a blood stem cell transplant + chemotherapy program for facial myeloma, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease diagnosis, and a summary of how international medical service procedures are regulated. (Figure from Liu5 Liu's official news reports and medical scenarios)